HUMAN LYMPHOKINE-ACTIVATED KILLER CELLS DEVELOP SYNGENEIC KILLING ABILITY

被引：0

作者：

GALLAGHER, G ^{[1
]}

FINDLAY, J ^{[1
]}

ALAZZAWI, FAL ^{[1
]}

机构：

[1] UNIV CAMBRIDGE,ADDENBROOKES HOSP,DEPT OBSTET & GYNAECOL,CAMBRIDGE,ENGLAND

来源：

IMMUNOLOGY | 1989年 / 66卷 / 03期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：471 / 474

页数：4

共 10 条

[1] IMMUNOSCINTIGRAPHY OF METASTASES WITH RADIOLABELED HUMAN-ANTIBODIES [J].

ALAZZAWI, F ;

SMITH, J ;

STIMSON, WH .

BRITISH MEDICAL JOURNAL, 1987, 294 (6571) :545-546

[2]

ALAZZAWI F, 1987, J CLIN LAB IMMUNOL, V22, P71

[3]

BROOKS B, 1988, CLIN EXP IMMUNOL, V74, P162

[4]

DAMLE NK, 1986, J IMMUNOL, V137, P2814

[5]

GALLAGHER G, 1988, CLIN EXP IMMUNOL, V74, P166

[6] LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].

GRIMM, EA ;

MAZUMDER, A ;

ZHANG, HZ ;

ROSENBERG, SA .

JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841

[7]

KALLAND T, 1987, J IMMUNOL, V138, P3640

[8]

PAIETTA E, 1987, LEUKOCYTE TYPING, V3, P528

[9] CANCER-IMMUNOTHERAPY USING INTERLEUKIN-2 AND INTERLEUKIN-2-ACTIVATED LYMPHOCYTES [J].

ROSENBERG, SA ;

LOTZE, MT .

ANNUAL REVIEW OF IMMUNOLOGY, 1986, 4 :681-709

[10] IMMUNOTHERAPY OF CANCER USING INTERLEUKIN-2 - CURRENT STATUS AND FUTURE-PROSPECTS [J].

ROSENBERG, SA .

IMMUNOLOGY TODAY, 1988, 9 (02) :58-62

← 1 →